secwatch.observer — SEC 8-K summary
======================================

Issuer:     Varex Imaging Corp (VREX)
CIK:        0001681622
Form:       8-K
Filed at:   2025-02-06T23:59:59+00:00
Accession:  0001681622-25-000013
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Varex Q1 FY2025 revenue up 5% YoY to $200M; GAAP net loss $0.01/sh, Non-GAAP EPS $0.07
--------------------------------------------------------------------------------

- Medical segment revenue $145M (+3% YoY); Industrial segment revenue $55M (+10% YoY).
- Non-GAAP gross margin improved to 35% from 31% in prior-year quarter.
- Cash flow from operations $10M; cash & securities $219M vs $213M at FY2024 year-end.
- Q2 FY2025 guidance: revenue $200-215M, Non-GAAP EPS $0.05-0.20.
- CEO cited solid demand and favorable sales mix driving higher-than-expected profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681622/000168162225000013/0001681622-25-000013-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681622/000168162225000013/vrex-20250206.htm
  HTML page:      https://secwatch.observer/filing/0001681622-25-000013

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer